Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT01107522
What this trial is testing

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Who this might be right for
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Tactical Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00004146
What this trial is testing

Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00441142
What this trial is testing

Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Patrick Y. Wen, MD 119
Testing effectiveness (Phase 2)Study completedNCT01062399
What this trial is testing

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 279
Testing effectiveness (Phase 2)Looking for participantsNCT07670026
What this trial is testing

Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression

Who this might be right for
Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 31
Testing effectiveness (Phase 2)Study completedNCT02364206
What this trial is testing

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Adult Glioblastoma
Centre Jean Perrin 18
Testing effectiveness (Phase 2)Study completedNCT00003751
What this trial is testing

Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Early research (Phase 1)Ended earlyNCT03705351
What this trial is testing

Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

Who this might be right for
GlioblastomaCancer of BrainGlioblastoma Multiforme+1 more
Providence Health & Services 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03581292
What this trial is testing

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Who this might be right for
Anaplastic AstrocytomaGlioblastomaMalignant Glioma
National Cancer Institute (NCI) 38
Large-scale testing (Phase 3)Study completedNCT02667587
What this trial is testing

An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Neoplasms
Bristol-Myers Squibb 716
Not applicableWithdrawnNCT03956706
What this trial is testing

Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas

Who this might be right for
GlioblastomaAstrocytoma, Grade IIIAstrocytoma, Grade IV+1 more
Northwell Health
Testing effectiveness (Phase 2)Ended earlyNCT02046187
What this trial is testing

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma (GBM)
St. Joseph's Hospital and Medical Center, Phoenix 14
Testing effectiveness (Phase 2)Study completedNCT01220271
What this trial is testing

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioma
Eli Lilly and Company 75
Early research (Phase 1)Looking for participantsNCT04903795
What this trial is testing

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Not applicableWithdrawnNCT04218019
What this trial is testing

Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation

Who this might be right for
Newly Diagnosed Glioblastoma in Patients ≥70 Years
Juergen Debus
Testing effectiveness (Phase 2)Study completedNCT03463265
What this trial is testing

Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma

Who this might be right for
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
Aadi Bioscience, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT00597402
What this trial is testing

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

Who this might be right for
GlioblastomaGliosarcomaBrain Tumor
Duke University 125
Testing effectiveness (Phase 2)WithdrawnNCT02599090
What this trial is testing

Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00905060
What this trial is testing

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 70
Early research (Phase 1)Study completedNCT06665724
What this trial is testing

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Who this might be right for
Anaplastic Astrocytoma (AA)Anaplastic Oligodendroglioma (AO)Glioblastoma (GBM)
Universität Münster 16
Next Page